The CACHE hit-finding competition highlights the potential of AI to identify small molecules that bind to hard-to-drug targets — and the long road ahead for these computational screening approaches.

The autoimmune response of Covid 19 patients works on the same principle, and offer an opportunity for drug designers to tackle this serious medical conditions. SciTech Pharma with its SigmaHit Drug Design Program, plan to design a drug for Covid 19, thus offering one of the many solutions to this global pandermic.

SciTech Pharma is pursuing opportunities in this important category involving CNS. Using our proprietary SigmaHit program, we are seeking to find solutions in an innovative way, to meet the challenges that these diseases have posed to the pharmaceutical industry for such a long time.